Bandy-Plus 12 Chewable Tablet
By Bandy-Plus
Rx
1 Chewable Tablet in a Strip

Composition
Ivermectin(12mg) + Albendazole(400mg)

Manufacturer - Mankind Pharma Ltd
208, Okhla Industrial Estate, Phase III, New Delhi - 110020

Expires on or after
December, 2025

liver
When taking Bandy-Plus 12 Chewable Tablet, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when using this medication. It is advised to consult your doctor before starting Bandy-Plus 12 Chewable Tablet. Be mindful of any signs of jaundice such as yellowing of the eyes and skin, itching, and clay colored stools while on this medication. If you experience any of these symptoms, inform your doctor promptly.

kidney
Bandy-Plus 12 Chewable Tablet appears safe for use in patients with kidney disease. Data shows dose adjustment may not be necessary. Consult your doctor before use.

alcohol
When taking Bandy-Plus 12 Chewable Tablet, be careful as it may lead to increased drowsiness when consumed with alcohol.

driving
When taking Bandy-Plus 12 Chewable Tablet, avoid driving if you feel sleepy, dizzy, or experience vision changes. These effects can impact your alertness.

pregnancy
Bandy-Plus 12 Chewable Tablet is considered unsafe during pregnancy. Animal studies have shown potential harm to the developing baby. Consult your doctor for a thorough evaluation of benefits and risks before use.

breastfeeding
Bandy-Plus 12 Chewable Tablet is likely safe for breastfeeding. Human data shows minimal risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹39.58
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024